Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicine for treating leukopenia caused by chronic hepatitis B or interferon and preparation method thereof

A technology for chronic hepatitis B and leukopenia, which is used in pharmaceutical formulations, extracellular fluid diseases, and medical preparations containing active ingredients, etc. It can solve the problems of single drug ingredients, poor efficacy and high price

Inactive Publication Date: 2011-08-31
慕少英
View PDF2 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Among them, most of them are in benign process, but those caused by chronic hepatitis B and its treatment (the most common is the adverse reaction of interferon) should be treated with Lexogen, Bakelyl Alcohol, Diyu Shengbai Tablet, etc. It is still effective, and the curative effect is not good for relapse patients, and the above-mentioned drugs have single ingredients, high prices, and the curative effect is not easy to last

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Example 1: Taking the manufacture of pills as an example, take 20 grams of astragalus, 7 grams of angelica, 12 grams of codonopsis, 12 grams of rehmannia, 12 grams of white peony, 12 grams of trigonum, 12 grams of curcuma, and 3 grams of roasted licorice; Mix well and clean; then put the cleaned raw materials into a drying box to dry, then grind them into granules, and then use a 100-mesh sieve to sieve the ground raw materials, and filter out the small particles for future use. Use, the large particles are ground into powder and sieved; then put 90 grams of honey into the pot and refine it with low heat until it is condensed into a syrupy shape, and it will not burn when stirred; finally, mix the refined honey with the above powdered medicine and knead evenly. Leave it for about half an hour, knead and press again to make a honeyed pill of about 6 grams;

Embodiment 2

[0025] Example 2: Taking the manufacture of Yaomo granules as an example, take 28 grams of Radix Astragali, 8 grams of Angelica, 10 grams of Codonopsis Radix, 10 grams of Radix Rehmanniae Radix Radix Radix Radixe Radix, 11 grams of Radix Paeoniae Alba, 11 grams of Sanleng, 11 grams of Curcuma Curcumae, and 4 grams of Radix Glycyrrhizae; The above raw materials are mixed and cleaned; then the cleaned raw materials are put into a drying box to dry, and then ground into granules. For later use, the larger particles are ground and sieved, and finally bagged in units of 6 grams;

Embodiment 3

[0026] Embodiment 3: Taking the manufacture of capsules as an example, take 30 grams of astragalus, 8 grams of angelica, 10 grams of codonopsis, 10 grams of rehmannia root, 10 grams of white peony, 10 grams of trigonum, 10 grams of curcuma, and 5 grams of roasted licorice; Mix well and clean; then put the cleaned raw materials into a drying box to dry, then grind them into granules, and then use a 100-mesh sieve to sieve the ground raw materials, and filter out the small particles for preparation For later use, the larger particles are ground into powder and sieved, and finally 0.5 grams are packed into capsules.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a medicine for treating leukopenia caused by chronic hepatitis B or interferon and preparation method thereof. The medicine is characterized by being prepared from the following important ingredients: 20 to 30 grams of astragalus root, 6 to 10 grams of Chinese angelica, 8 to 12 grams of common burreed rhizome, 8 to 12 grams of curcuma phaeocaulis valeton, 8 to 12 grams of prepared rehmannia root, 8 to 12 grams of white paeony root, 8 to 12 grams of hairy asiabell root, and 3 to 5 grams of fried liquorice. The preparation method of the medicine comprises following steps of cleaning the above ingredients, sieving, refining honey, and then, producing medicinal pills. The medicine has advantages of simpleness in preparation, convenience in taking, excellent and durable curative effect, no toxic or side effects, and low cost, and is especially suitable for treating patients with leukopenia caused by chronic hepatitis B or interferon.

Description

Technical field: [0001] The invention relates to a Chinese herbal medicine, in particular to a medicine for treating leukopenia caused by chronic hepatitis B or interferon and a preparation method thereof. Background technique: [0002] Chronic hepatitis B is one of the common chronic infectious diseases in my country, which seriously endangers people's health. Leukopenia is a common condition in the course of its pathogenesis and treatment. Leukopenia refers to the peripheral blood white blood cell count continuously lower than the normal value of 4 × 10 9 / L, there are many pathogenic factors, such as ionizing radiation, chemical poisons (such as benzene, etc.), cell poisons, nutritional deficiencies, malignant tumors, leukemia, viral hepatitis, etc. Among them, most of them are in benign process, but those caused by chronic hepatitis B and its treatment (the most common is the adverse reaction of interferon) should be treated with Lexogen, Bakelyl Alcohol, Diyu Shengbai ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9066A61K9/20A61P7/00A61P1/16A61P31/20
Inventor 慕少英陈桂兰姜冠羽
Owner 慕少英
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com